Bitcoin Treasuries Can Outperform BTC… But Is The Risk Worth Taking?
Susan Bobulsky, Chief Commercial Officer for Adaptive Biotechnologies Corp (), sold 3,000 shares of common stock for a total of $75,000 on August 10, 2026. The shares were sold at a price of $25.00 each. The timing coincides with the stock
